The report reads really well. One great sales point given the current restrictions is that everyone can wok using it remotely because it's provided as a SaaS product (software as a service) ...
"physicians and patients alike to access and report on cases from any device with a browser. As a result, HIRUKO is well-placed to meet the needs of professionals operating within current [COVID-19] restrictions"
Another interesting point towards the back of the report was the "new product development" where the Artificial Intelligence module can identify potential COVID-19 symptoms....
"Stella COVID-19 identifies NORMAL X-rays and possible pathological patterns for COVID-19 pneumonia on a chest CR/DX AP/PA board"
Ann: Q1 Quarterly Activity Report & Appendix 4C, page-5
-
- There are more pages in this discussion • 30 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IME (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
48.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $21.89M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 7707 | 45.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 51.0¢ | 3000 | 1 |
View Market Depth
| Last trade - 16.12pm 13/09/2024 (20 minute delay) ? |
| IME (ASX) Chart |
Day chart unavailable